Since we revealed that ZDHHC7 increases MAVS oligomerization and enhances type I interferon production, inhibition of ZDHHC7 might be a therapeutic strategy alleviating these autoimmune diseases. This evidence concerns the gene ZDHHC7 and autoimmune disease.